was read the article
array:23 [ "pii" => "S1579212916000288" "issn" => "15792129" "doi" => "10.1016/j.arbr.2016.02.003" "estado" => "S300" "fechaPublicacion" => "2016-04-01" "aid" => "1214" "copyright" => "SEPAR" "copyrightAnyo" => "2015" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2016;52:229" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1676 "formatos" => array:3 [ "EPUB" => 120 "HTML" => 1088 "PDF" => 468 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0300289615002549" "issn" => "03002896" "doi" => "10.1016/j.arbres.2015.06.004" "estado" => "S300" "fechaPublicacion" => "2016-04-01" "aid" => "1214" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2016;52:229" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5071 "formatos" => array:3 [ "EPUB" => 122 "HTML" => 4030 "PDF" => 919 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "Corticoides inhalados en enfermedad pulmonar obstructiva crónica: algunas consideraciones" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "229" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Inhaled corticosteroids in chronic obstructive pulmonary disease: Some considerations" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Adolfo Baloira Villar, Marta Núñez Fernández, Abel Pallarés Sanmartín" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Adolfo" "apellidos" => "Baloira Villar" ] 1 => array:2 [ "nombre" => "Marta" "apellidos" => "Núñez Fernández" ] 2 => array:2 [ "nombre" => "Abel" "apellidos" => "Pallarés Sanmartín" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212916000288" "doi" => "10.1016/j.arbr.2016.02.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212916000288?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289615002549?idApp=UINPBA00003Z" "url" => "/03002896/0000005200000004/v1_201603270531/S0300289615002549/v1_201603270531/es/main.assets" ] ] "itemAnterior" => array:19 [ "pii" => "S1579212915003298" "issn" => "15792129" "doi" => "10.1016/j.arbr.2015.10.015" "estado" => "S300" "fechaPublicacion" => "2016-04-01" "aid" => "1253" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Arch Bronconeumol. 2016;52:227-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1591 "formatos" => array:3 [ "EPUB" => 113 "HTML" => 1001 "PDF" => 477 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Rhinoconjunctivitis and Occupational Asthma in a Furniture Factory Worker" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "227" "paginaFinal" => "228" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Rinoconjuntivitis y asma ocupacional en una trabajadora de una fábrica de muebles" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1513 "Ancho" => 2511 "Tamanyo" => 193686 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Bronchial provocation test with rye flour.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Elisa Gómez-Torrijos, Mendez Núñez, Rosa García Rodríguez" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Elisa" "apellidos" => "Gómez-Torrijos" ] 1 => array:2 [ "nombre" => "Mendez" "apellidos" => "Núñez" ] 2 => array:2 [ "nombre" => "Rosa García" "apellidos" => "Rodríguez" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0300289615003671" "doi" => "10.1016/j.arbres.2015.08.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289615003671?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212915003298?idApp=UINPBA00003Z" "url" => "/15792129/0000005200000004/v2_201604010234/S1579212915003298/v2_201604010234/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Some Considerations" "tieneTextoCompleto" => true "saludo" => "To the Editor:" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "229" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Adolfo Baloira Villar, Marta Núñez Fernández, Abel Pallarés Sanmartín" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Adolfo" "apellidos" => "Baloira Villar" "email" => array:1 [ 0 => "adolfo.baloira.villar@sergas.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Marta" "apellidos" => "Núñez Fernández" ] 2 => array:2 [ "nombre" => "Abel" "apellidos" => "Pallarés Sanmartín" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Neumología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Corticoides inhalados en enfermedad pulmonar obstructiva crónica: algunas consideraciones" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We read with great interest the consensus document on the use of inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease (COPD), published in <span class="elsevierStyleSmallCaps">Archivos de Bronconeumología</span>,<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a> and we would like to consider some aspects.</p><p id="par0010" class="elsevierStylePara elsevierViewall">The use of ICS in COPD remains a controversial subject, and a good number of studies argue either for it or against it. The main indication, which moreover achieves 100% consensus in the above-mentioned document, is in patients with COPD/asthma overlap syndrome – but the problem lies in defining this phenotype.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> A previous diagnosis of asthma may be the best criterion, but this approach assumes that the asthma diagnosis is correct, which may not always be the case.</p><p id="par0015" class="elsevierStylePara elsevierViewall">The other most widely accepted indication is in frequent exacerbations. Several review articles have questioned whether the modest improvement achieved is clinically relevant for the patient. We were interested to see that the weight of consensus on whether to add ICS to the treatment of patient with frequent exacerbations, irrespective of their FEV<span class="elsevierStyleInf">1</span> value shifted significantly (54% vs 92%) between the first and second round of questions. This is probably a reflection of the participants’ uncertainty, possibly fueled by studies such as Withdrawal of Inhaled Steroids during Optimized Bronchodilator Management (WISDOM) and Indacaterol: Switching Nonexacerbating Patients with moderate COPD from Salmeterol/Fluticasone to Indacaterol (INSTEAD). Although the final result was taken as consensus, perhaps such a dramatic change should be studied in greater depth.</p><p id="par0020" class="elsevierStylePara elsevierViewall">We would also like to examine the lack of agreement regarding the withdrawal of ICS in the case of eosinophilia. Evidence is growing on the role of elevated blood eosinophils in predicting COPD exacerbations. A recent study of fluticasone/vilanterol compared to vilanterol alone showed that exacerbations were only significantly reduced when blood eosinophilia was >2%, and that a much greater effect was found when eosinophil levels exceeded 6%.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> The consensus panel does not appear to be convinced of the benefit of ICS in exacerbations caused by infectious processes, since 37.5% agreed in the first round and 52% in the second. Bafadhel et al.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a> point out that blood eosinophilia is a principal biomarker for non-infectious exacerbations, correlating with response to steroids during exacerbations.</p><p id="par0025" class="elsevierStylePara elsevierViewall">We, personally, agree with Ernst et al.,<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a> who found that the best current marker for favorable response to ICS in COPD is the presence of eosinophilia. More biomarkers are needed for determining which patients within the wide spectrum of COPD will benefit most from long-term treatment with ICS.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Baloira Villar A, Núñez Fernández M, Pallarés Sanmartín A. Corticoides inhalados en enfermedad pulmonar obstructiva crónica: algunas consideraciones. Arch Bronconeumol. 2016;52:236.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Documento de consenso «Uso adecuado de los corticoides inhalados en la enfermedad pulmonar obstructiva crónica»" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "B. Alcázar Navarrete" 1 => "C. Casanova" 2 => "M. Miravitlles" 3 => "P. de Lucas" 4 => "J.A. Riesco" 5 => "J.M. Rodríguez González-Moro" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.arbres.2014.11.001" "Revista" => array:6 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2015" "volumen" => "51" "paginaInicial" => "193" "paginaFinal" => "198" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25540900" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The asthma COPD overlap syndrome (ACOS)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S. Bujarski" 1 => "A.D. Parulekar" 2 => "A. Sharafkhaneh" 3 => "N.A. Hanania" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11882-014-0509-6" "Revista" => array:5 [ "tituloSerie" => "Curr Allergy Asthma Rep" "fecha" => "2015" "volumen" => "15" "paginaInicial" => "509" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25712010" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S. Pascoe" 1 => "N. Locantore" 2 => "M.T. Dransfield" 3 => "N.C. Barnes" 4 => "I.D. Pavord" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S2213-2600(15)00106-X" "Revista" => array:6 [ "tituloSerie" => "Lancet Respir Med" "fecha" => "2015" "volumen" => "3" "paginaInicial" => "435" "paginaFinal" => "442" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25878028" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Bafadhel" 1 => "S. McKenna" 2 => "S. Terry" 3 => "V. Mistry" 4 => "C. Reid" 5 => "P. Haldar" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.201104-0597OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2011" "volumen" => "184" "paginaInicial" => "662" "paginaFinal" => "671" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21680942" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inhaled corticosteroids in COPD: the clinical evidence" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P. Ernst" 1 => "N. Saad" 2 => "S. Suissa" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.00128914" "Revista" => array:7 [ "tituloSerie" => "Eur Respir J" "fecha" => "2015" "volumen" => "45" "paginaInicial" => "525" "paginaFinal" => "537" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25537556" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0140673600021401" "estado" => "S300" "issn" => "01406736" ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15792129/0000005200000004/v2_201604010234/S1579212916000288/v2_201604010234/en/main.assets" "Apartado" => array:4 [ "identificador" => "49862" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letter to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15792129/0000005200000004/v2_201604010234/S1579212916000288/v2_201604010234/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212916000288?idApp=UINPBA00003Z" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 5 | 3 | 8 |
2024 October | 36 | 18 | 54 |
2024 September | 35 | 17 | 52 |
2024 August | 68 | 31 | 99 |
2024 July | 38 | 21 | 59 |
2024 June | 54 | 36 | 90 |
2024 May | 76 | 32 | 108 |
2024 April | 31 | 26 | 57 |
2024 March | 45 | 14 | 59 |
2024 February | 27 | 21 | 48 |
2023 March | 5 | 3 | 8 |
2023 February | 27 | 14 | 41 |
2023 January | 25 | 35 | 60 |
2022 December | 33 | 26 | 59 |
2022 November | 40 | 29 | 69 |
2022 October | 32 | 29 | 61 |
2022 September | 21 | 25 | 46 |
2022 August | 30 | 31 | 61 |
2022 July | 24 | 45 | 69 |
2022 June | 20 | 24 | 44 |
2022 May | 31 | 32 | 63 |
2022 April | 24 | 20 | 44 |
2022 March | 25 | 34 | 59 |
2022 February | 27 | 31 | 58 |
2022 January | 26 | 30 | 56 |
2021 December | 19 | 36 | 55 |
2021 November | 34 | 37 | 71 |
2021 October | 32 | 43 | 75 |
2021 September | 31 | 46 | 77 |
2021 August | 28 | 33 | 61 |
2021 July | 24 | 19 | 43 |
2021 June | 30 | 41 | 71 |
2021 May | 38 | 38 | 76 |
2021 April | 62 | 70 | 132 |
2021 March | 56 | 23 | 79 |
2021 February | 32 | 23 | 55 |
2021 January | 36 | 9 | 45 |
2020 December | 37 | 19 | 56 |
2020 November | 28 | 25 | 53 |
2020 October | 20 | 12 | 32 |
2020 September | 19 | 9 | 28 |
2020 August | 23 | 18 | 41 |
2020 July | 28 | 14 | 42 |
2020 June | 39 | 12 | 51 |
2020 May | 25 | 22 | 47 |
2020 April | 30 | 14 | 44 |
2020 March | 34 | 15 | 49 |
2020 February | 32 | 15 | 47 |
2020 January | 29 | 14 | 43 |
2019 December | 33 | 16 | 49 |
2019 November | 31 | 16 | 47 |
2019 October | 19 | 13 | 32 |
2019 September | 23 | 6 | 29 |
2019 August | 28 | 10 | 38 |
2019 July | 27 | 15 | 42 |
2019 June | 16 | 4 | 20 |
2019 May | 38 | 9 | 47 |
2019 April | 61 | 17 | 78 |
2019 March | 25 | 15 | 40 |
2019 February | 25 | 17 | 42 |
2019 January | 30 | 9 | 39 |
2018 December | 22 | 17 | 39 |
2018 November | 44 | 16 | 60 |
2018 October | 50 | 14 | 64 |
2018 September | 36 | 9 | 45 |
2018 May | 12 | 0 | 12 |
2018 April | 32 | 7 | 39 |
2018 March | 22 | 5 | 27 |
2018 February | 29 | 7 | 36 |
2018 January | 16 | 5 | 21 |
2017 December | 33 | 7 | 40 |
2017 November | 20 | 14 | 34 |
2017 October | 23 | 6 | 29 |
2017 September | 17 | 10 | 27 |
2017 August | 22 | 13 | 35 |
2017 July | 16 | 7 | 23 |
2017 June | 30 | 14 | 44 |
2017 May | 24 | 11 | 35 |
2017 April | 43 | 13 | 56 |
2017 March | 19 | 23 | 42 |
2017 February | 13 | 2 | 15 |
2017 January | 13 | 5 | 18 |
2016 December | 22 | 11 | 33 |
2016 November | 21 | 24 | 45 |
2016 October | 26 | 25 | 51 |
2016 September | 17 | 17 | 34 |
2016 August | 37 | 7 | 44 |
2016 July | 28 | 8 | 36 |